Medical ConditionsCraniofacial & dental genetics: Mucopolysaccharidoses
Medical ConditionsCraniofacial & dental genetics: Mucopolysaccharidoses
Mucopolysaccharidoses
Overview
Board takeaway: Identify the subtype and evaluate airway obstruction, cervical instability, and cardiac disease before anesthesia or restrictive positioning.
What are mucopolysaccharidoses and how do the types differ?
Deficient lysosomal enzymes impair glycosaminoglycan degradation. Types include I (Hurler spectrum), II (Hunter), III (Sanfilippo), IV (Morquio), VI (Maroteaux–Lamy), VII (Sly), and rare IX. Most are autosomal recessive; type II is X-linked. The stored substrate, organs involved, and neurologic course differ by type.
Which systemic findings matter for dental treatment in mucopolysaccharidoses?
Short stature, skeletal dysplasia, joint restriction, spinal deformity or instability, upper-airway tissue enlargement, abnormal tracheal anatomy, sleep apnea, cardiac disease, and hearing or vision impairment may occur. Cognition ranges from preserved to progressive decline. Cervical cord compression or atlantoaxial instability can make neck movement dangerous.
What oral findings occur in mucopolysaccharidoses?
Coarse facial features, thick lips, macroglossia, gingival enlargement, limited opening, and condylar or temporomandibular abnormalities are reported. Dental findings may include open bite, crossbite, crowding, delayed eruption, impaction, abnormal follicles, enamel defects, or taurodontism. Subtype and severity determine which are present.
How should dental care be planned for mucopolysaccharidoses?
- Establish subtype and status: cardiac, airway, cervical, swallowing, and developmental needs.
- Prevent disease: caregiver-supported hygiene, fluoride, and regular assessment tailored to risk.
- Protect positioning: avoid forced neck movement or maneuvers that compromise breathing.
- Plan anesthesia with specialists: airway difficulty and cervical disease may require an experienced hospital team and postoperative respiratory support.
- Avoid blanket choices: stabilization or sedation must be assessed for the individual; neither is automatically appropriate because cooperation is difficult.
What treatment and prognosis apply to mucopolysaccharidoses?
Enzyme replacement and hematopoietic transplantation have subtype-specific indications and limits, particularly for neurologic disease. Multidisciplinary treatment addresses cardiac, skeletal, respiratory, sensory, and functional problems. Prognosis varies greatly by subtype and severity; one untreated historic lifespan cannot describe the group.